FemTech Startups

Apryl (Progyny Global) offers a fertility benefits platform that connects employees with fertility experts, clinics, and treatments including IVF, egg and sperm freezing, surrogacy, adoption, and menopause management. It serves companies as an employee benefit to support talent attraction, retention, and DEI strategies, with coverage across Europe, Asia, and Australia.

4 investors

Biologica produces stage-specific effervescent multivitamin drinks formulated for women's hormonal health at different life stages. The products combine vitamins, minerals, probiotics, and electrolytes to address both acute hormonal symptoms and overall wellness across brain, heart, bones, and muscles.

4 investors

Cadenza Bio develops small-molecule drugs for oral administration to treat demyelinating and inflammatory diseases. The company focuses on halting disease progression and promoting tissue repair in patients with debilitating conditions.

4 investors

Carrot is a global platform providing fertility care and family-building support to millions of people. The company serves individuals seeking reproductive health services and related care across pre-pregnancy, maternity, and menopause stages.

4 investors

Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women. It focuses on evidence-based therapies for life-threatening complications of pregnancy.

4 investors

Conceive offers a membership-based fertility support service that connects members with nurses and coaches available 24/7 via text for personalized coaching, help interpreting fertility testing, and guidance through trying to conceive, IVF, treatment, and pregnancy. It also runs live sessions led by fertility doctors, embryologists, and nurses for education.

4 investors

Diem is a search engine designed as a social platform where users can ask questions and engage with a community, resembling an intimate conversational space similar to Reddit.

4 investors

Elvie develops app-connected, hospital-grade wearable breast pumps and a smart bouncer that converts into a bassinet, sold direct to consumers and via insurance. The company makes breastfeeding and baby-care products for mothers and became part of the Willow family in 2025.

4 investors

Ema is a clinical AI layer that runs on top of frontier models to add medical judgment, safety guardrails, and clinical rubrics for health and wellness products. It targets companies building AI features in care settings, with an emphasis on women's health, and turns user conversations into de-identified signals teams can act on.

4 investors

Freya Biosciences is a clinical-stage immunology company developing therapies targeting inflammation and immune dysregulation in conditions affecting women, including infertility and pregnancy-related dysbiosis. It focuses on disease-modifying treatments in the underserved area of women's health.

4 investors

Gabbi offers a clinically-validated online breast cancer risk assessment and virtual visits with nurse practitioners who create personalized care plans and order tests or imaging. It partners with health systems, employers, and providers to identify at-risk women and route them to early detection and screening.

4 investors

Hazel makes disposable briefs designed for women experiencing bladder leaks, offering underwear-like products with a control top. The brand markets to women, including those going through menopause and incontinence.

4 investors

Vitra develops reproductive therapies that mature eggs outside the body in a controlled environment, aiming to reduce or eliminate the hormone injections required in conventional IVF. The women-led biotech company builds technology intended to fit existing IVF clinical workflows to make fertility care safer and more accessible for patients and clinicians.

4 investors

inne makes the Minilab, a CE-certified saliva-based fertility and cycle tracker that measures progesterone from a daily saliva sample to identify fertile days as a hormone-free contraceptive and conception aid. Aimed at women aged 18+ with regular cycles, the device pairs with a mobile app and is available in the EU and UK.

4 investors

iSono Health develops an automated ultrasound system combined with artificial intelligence for breast imaging at the point of care, enabling standardized and accessible imaging across different healthcare settings.

4 investors

LunaJoy is a mental health platform that connects women facing postpartum challenges with mental health providers. The company handles administrative tasks including billing, credentialing, and scheduling while providers deliver care through a flexible remote model integrated with insurance networks.

4 investors

Madorra develops a nonhormonal, noninvasive medical device to treat vaginal dryness and vulvovaginal atrophy, targeting post-menopausal people and breast cancer survivors. The company operates in the women's health medical device sector and has received FDA breakthrough device designation.

4 investors

Marlow makes organic, toxin-free and sustainable period care products designed for menstruating consumers. The Canadian, female-founded brand sells clean menstrual care items direct to consumers.

4 investors

MedZero provides employee benefits solutions focused on reproductive health and fertility coverage. The company serves benefits decision-makers and employers seeking to address infertility support and reproductive healthcare needs.

4 investors

Natural Cycles offers an FDA-cleared mobile app that uses a user's body temperature data and an algorithm to predict fertile windows for hormone-free birth control and pregnancy planning. The app supports women's health across life stages from contraception through perimenopause and is certified in over 35 countries.

4 investors

Nodal operates a platform connecting surrogates (gestational carriers) and intended parents, with tools and education to support both parties through the surrogacy process. It combines technology with a team of clinicians, nurses, and former surrogates to make surrogacy more accessible and transparent.

4 investors

Oova offers a clinical-grade at-home hormone test that pairs with an AI-powered app to measure LH, estrogen (E3G), and progesterone (PdG) levels from urine, scanned via a smartphone camera. It serves women tracking fertility, conception, and perimenopause, providing daily lab-accurate hormone insights that can be shared with their doctors.

4 investors

Orchid offers whole genome sequencing-based genetic screening of embryos during IVF as well as preconception testing for couples, analyzing DNA to identify predispositions to monogenic diseases, chromosomal abnormalities, and polygenic risks. It serves prospective parents and IVF patients, delivering reports reviewed by board-certified genetic counselors.

4 investors

Roya makes skin health products with suggestions based on CDC data. The company serves consumers interested in skin health wellness.

4 investors